Skip to main content
. 2023 Dec 21;34(4):305–316.

Table 2:

Anti-Hypertensives-Induced Laboratory Changes in Diabetic Patients with Cardiovascular Complications

DRUGS ASSOCIATED LABORATORY CHANGES
ACE Inhibitors Azotaemia [11,12], Hyperbilirubinemia [41], elevates liver enzymes [41], reduces proteinuria [43]
Diuretics
a. Thiazide Dyslipidaemia [20-22], hypokalemia [14], hyponatremia [14], hypomagnesemia [23], hypercalcemia[18],hyperglyceamia[24,25],hyperuricemia[27]
b. Loop Hyponatremia[13],hypocalcemia[26],hypomagnesemia[23],hyperuricemia[27]
c. Potassium sparing Hyperkalemia[27], metabolic acidosis[27]
Beta blockers Dyslipidemia[28,29],hyperglycemia[34]
Centrally acting alpha 2 Adrenergic Agonist-methyldopa Hyperbilirubinemia[37],elevates liver enzymes[37], hypernatremia[37], hyperchloremia[37] hypermagnesemia[37], hyperkalemia[37]